Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.69 (
BMT
)
2,655
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
BRCA1 (breast cancer-associated gene 1) is a tumor suppressor gene that plays a role in DNA repair when phosphorylated. Many DNA-damaging agents including UVC and hydrogen peroxide have been shown to induce phosphorylation of BRCA1. Results of this study now show that both UVB and a bicyclic monoterpene diol (
BMT
diol) result in phosphorylation of BRCA1. This phosphorylation was maximal 2 h after treatment with either agent and declined to basal levels by 24 h. Inhibitor studies revealed that both UVB and the
BMT
diol phosphorylate BRCA1 through the
FK506-binding protein
-FKBP rapamycin-associated binding protein pathway, but the
BMT
diol also led to phosphorylation of BRCA1 through casein kinase II. This suggests that the signaling pathways for UVB and the
BMT
diol may diverge. Results of this study also show that the
BMT
diol stimulates the repair of UVB-induced cyclobutane pyrimidine dimers (CPD). Inhibitors of
BMT
diol-induced BRCA1 phosphorylation blocked the
BMT
diol-stimulated repair of CPD. This indicates that the
BMT
diol induces the phosphorylation of BRCA1, which, in turn, leads to an increase in repair of UVB-induced CPD. Therefore, this
BMT
diol may be useful for ameliorating the damaging effects of UVB.
...
PMID:A bicyclic monoterpene diol and UVB stimulate BRCA1 phosphorylation in human keratinocytes. 1285 82